You are here
- Home
- Total number of clinical trials
A multicenter, single arm, cohort study to evaluate the Efficacy and Safety of saxagliptin 5mg, once daily for 24 weeks, in patients with type 2 diabetes mellitus who are treatment naïve or who have inadequate glycaemic control on metformin alone
- Disease
- diabetes mellitus, diabetes type 2
- Drug Name
- Onglyza, saxagliptin
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Jan 18, 1971
- Study Name
- SUNSHINE
- ClinicalTrials.gov ID
- NCT01608724
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
